Immunitybio Inc (NASDAQ:IBRX)

5.70
Delayed Data
As of 4:00pm ET
 -0.195 / -3.31%
Today’s Change
2.60
Today|||52-Week Range
7.99
-6.33%
Year-to-Date
No recent news for Immunitybio Inc.

Today’s Trading

Previous close5.89
Today’s open5.88
Day’s range5.61 - 5.92
Volume31,506
Average volume (3 months)1,580,326
Market cap$2.5B
Data as of 4:00pm ET, 12/06/2022

Growth & Valuation

Earnings growth (last year)+0.13%
Earnings growth (this year)-12.36%
Earnings growth (next 5 years)-47.93%
Revenue growth (last year)+741.44%
P/E ratioNM
Price/Sales2,533.77
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RCUSArcus Biosciences In...-2.13-6.27%
----
BCRXBioCryst Pharmaceuti...-0.69-5.92%
MYOVMyovant Sciences Ltd+0.08+0.28%
Data as of 4:00pm ET, 12/06/2022

Financials

Last reporting dateNovember 11, 2022
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$934.0K
Annual profit (last year)-$346.8M
Net profit margin-37,129.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Diego, California

Forecasts